Interaction Guide · Research summary

Can I take Withania Somnifera with Diazepam?

Review Withania Somnifera with Diazepam: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Ashwagandha may add to diazepam-related drowsiness or impairment. The exact added risk is not measured, so review co-use with the prescriber before adding the product.

What this answer covers

Withania somnifera preparations; root-only and root/leaf extracts are not interchangeable.

Supplement or preparation
Withania somnifera
Medication ingredient
diazepam

The alertness effects may overlap

Diazepam can produce sedation and has active metabolites that persist. Supplement guidance describes drowsiness or cautions about other sedating substances, supporting a precaution without an exact-pair rate.

The evidence does not establish a fixed effect

The inspected supplement evidence does not measure diazepam co-use. Preparation and dose can change exposure, and root-only extracts should not be equated with every leaf-containing product.

Consider all medicines and the formulation

Oral, injected and nasal diazepam have different uses and instructions. Other sedatives, organ function and repeated dosing may affect impairment; no safe supplement dose or short gap is established.

Review use and respond to impairment

Tell the prescriber about the exact product and avoid driving while impaired. Do not change diazepam yourself. Slow breathing or unusual difficulty waking requires emergency help.

Evidence and practical considerations

Side effects & toxicity

Conditional additive-drowsiness precaution from exact diazepam labels and identified-species supplement guidance; no exact combination rate or validated spacing.

Exact scope
Withania somnifera preparations; root-only and root/leaf extracts are not interchangeable. with Diazepam3322 IN; oral, IV/IM and intranasal formulations, active metabolites and study-route limits.
Medication form and route
oral medication; intravenous medication; intramuscular medication; intranasal medication; oral supplement

What remains uncertain

  • No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.

Factors that may matter: Preparation; Dose; Other medicines; Organ function.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed diazepam

CNS-depressant risk; CYP3A4/2C19 formation of active metabolites with prolonged elimination.

How this applies: Exact diazepam RxCUI 3322 IN, with stated salt/formulation/route bridge.

Not midazolam metabolism or proof of exact botanical risk.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed diazepam

Sedation and respiratory precautions with other CNS depressants.

How this applies: Exact diazepam RxCUI 3322 IN, with stated salt/formulation/route bridge.

Bypasses intestinal absorption; oral juice exposure magnitude cannot be transferred.

Source 3: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed diazepam

CNS-depressant and metabolism-related interaction precautions; exact rescue dosing directions.

How this applies: Exact diazepam RxCUI 3322 IN, with stated salt/formulation/route bridge.

Not oral-study dosing or a basis to delay prescribed rescue treatment; rectal preparations not directly studied here.

Source 4: federal supplement guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: Ashwagandha users

Drowsiness possible; potential interactions with sedatives; preparation and long-term safety limitations.

How this applies: Supplement-specific sedation precaution.

Not an exact diazepam co-use trial or adverse-event rate; roots and leaf-containing extracts differ.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Research summary published
Article prepared
Prepared exact diazepam article with formulation-specific evidence and uncertainty.

Article revision: 737bc48e802071df

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.